Search
ALX Oncology Holdings Inc
ALXOAdd to Watchlist
1.370USD
+0.150+12.30%
Close 11-02 16:00（ET）
171.14MMarket Cap
LossP/E TTM
Today
+12.30%
5 Days
+21.24%
1 Month
+12.30%
6 Months
-18.93%
Year to Date
+21.24%
1 Year
-11.04%
Key Figures
1.230Open
1.420High
516.81KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.41%Turnover Ratio
1.220Prev. Close
1.200Low
692.93KTurnover
LossP/E Static
1.26P/B
0.00%Div Yield TTM
-59.40%ROA
2.66052wk High
110.09Volume Ratio
-134.85MNet Profit
124.92MShares
-1.4903EPS TTM
0.44Beta
-74.17%ROE
0.86252wk Low
18.44%Amplitude
--Gross Margin
171.14MMarket Cap
0.31Reward/Risk
5.80%Risk Rate
ALX Oncology Holdings Inc's Score
0.15vs previous score
Forecast8.00
Financial Health5.40
Technical6.57
Valuation Dimensions6.36
Institutional Confidence3.00
Risk Assessment3.06
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
ALX Oncology Holdings Inc Technical Analysis
Technical Indicators
Buy
Summary
Neutral
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.13/-0.14
Revenue / Forecast
--/0.00
ALX Oncology Holdings Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolALXO
Number of employees80
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| RA Capital Management, LP | 9.75% |
| VenBio Partners LLC | 9.58% |
| HBM Partners AG | 3.34% |
| Vanguard Capital Management, LLC | 3.11% |
| Shareholder Types | Proportion |
|---|---|
| Private Equity | 10.26% |
| Investment Advisor | 9.91% |
| Venture Capital | 9.75% |
| Investment Advisor/Hedge Fund | 5.15% |
Related Instruments
-0.46%
-0.97%
-2.05%
-0.78%
+0.45%
-0.04%
-0.12%
-0.21%
+1.13%
+0.49%
-1.03%
+0.86%
+0.38%
+2.73%
+3.60%
-0.77%
-0.40%
-0.19%
+1.54%
-2.00%Popular Instruments
51806.000
-190.100 (-0.37%)
28195.100
+193.100 (+0.69%)
7554.000
+10.700 (+0.14%)
12797.000
-1.000 (-0.01%)
63264.000
+589.000 (+0.94%)
6186.200
+44.700 (+0.73%)
93.938
-1.348 (-1.42%)
338.320
-6.310 (-1.83%)
202.060
-2.580 (-1.26%)
3964.040
+18.260 (+0.46%)
FAQs
What is the current price of ALX Oncology Holdings Inc (ALXO)?
The current price of ALX Oncology Holdings Inc (ALXO) is 1.37.
What is the symbol of ALX Oncology Holdings Inc?
The ticker symbol of ALX Oncology Holdings Inc is ALXO.
What is the 52-week high of ALX Oncology Holdings Inc?
The 52-week high of ALX Oncology Holdings Inc is 2.66.
What is the 52-week low of ALX Oncology Holdings Inc?
The 52-week low of ALX Oncology Holdings Inc is 0.86.
What is the market capitalization of ALX Oncology Holdings Inc?
The market capitalization of ALX Oncology Holdings Inc is 171.14M.
Is ALX Oncology Holdings Inc (ALXO) currently rated as Buy, Hold, or Sell?
According to analysts, ALX Oncology Holdings Inc (ALXO) has an overall rating of Buy, with a price target of 4.60.
What is the Earnings Per Share (EPS TTM) of ALX Oncology Holdings Inc (ALXO)?
The Earnings Per Share (EPS TTM) of ALX Oncology Holdings Inc (ALXO) is -1.49.